120 related articles for article (PubMed ID: 35514015)
21. Ascertaining invasive breast cancer cases; the validity of administrative and self-reported data sources in Australia.
Kemp A; Preen DB; Saunders C; Holman CD; Bulsara M; Rogers K; Roughead EE
BMC Med Res Methodol; 2013 Feb; 13():17. PubMed ID: 23399047
[TBL] [Abstract][Full Text] [Related]
22. Factors Associated With Radiotherapy Utilisation In New South Wales, Australia: Results From The 45 and Up Study.
Yap ML; O'Connell DL; Goldsbury D; Weber M; Barton M
Clin Oncol (R Coll Radiol); 2020 May; 32(5):282-291. PubMed ID: 32007353
[TBL] [Abstract][Full Text] [Related]
23. Comorbidity and outcomes after surgery among women with breast cancer: analysis of nationwide in-patient sample database.
Dehal A; Abbas A; Johna S
Breast Cancer Res Treat; 2013 Jun; 139(2):469-76. PubMed ID: 23624816
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy utilization in developing countries: An IAEA study.
Rosenblatt E; Fidarova E; Zubizarreta EH; Barton MB; Jones GW; Mackillop WJ; Cordero L; Yarney J; Lim G; Gan JV; Cernea V; Stojanovic-Rundic S; Strojan P; Kochbati L; Quarneti A
Radiother Oncol; 2018 Sep; 128(3):400-405. PubMed ID: 29859755
[TBL] [Abstract][Full Text] [Related]
25. Frailty and comorbidity in predicting community COVID-19 mortality in the U.K. Biobank: The effect of sampling.
Mak JKL; Kuja-Halkola R; Wang Y; Hägg S; Jylhävä J
J Am Geriatr Soc; 2021 May; 69(5):1128-1139. PubMed ID: 33619733
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer treatment and survival differences in women in remote and socioeconomically disadvantaged areas, as demonstrated by linked data from New South Wales (NSW), Australia.
Buckley E; Elder E; McGill S; Kargar ZS; Li M; Roder D; Currow D
Breast Cancer Res Treat; 2021 Jul; 188(2):547-560. PubMed ID: 33748922
[TBL] [Abstract][Full Text] [Related]
27. Optimizing the measurement of comorbidity for a South Australian colorectal cancer population using administrative data.
Pule L; Buckley E; Niyonsenga T; Roder D
J Eval Clin Pract; 2020 Aug; 26(4):1250-1258. PubMed ID: 31721394
[TBL] [Abstract][Full Text] [Related]
28. Increasing rates of surgical treatment and preventing comorbidities may increase breast cancer survival for Aboriginal women.
Supramaniam R; Gibberd A; Dillon A; Goldsbury DE; O'Connell DL
BMC Cancer; 2014 Mar; 14():163. PubMed ID: 24606675
[TBL] [Abstract][Full Text] [Related]
29. Patterns of comorbidities in women with breast cancer: a Canadian population-based study.
Ng HS; Vitry A; Koczwara B; Roder D; McBride ML
Cancer Causes Control; 2019 Sep; 30(9):931-941. PubMed ID: 31280456
[TBL] [Abstract][Full Text] [Related]
30. The effect of travel distance on radiotherapy utilization in NSW and ACT.
Gabriel G; Barton M; Delaney GP
Radiother Oncol; 2015 Nov; 117(2):386-9. PubMed ID: 26243679
[TBL] [Abstract][Full Text] [Related]
31. Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000-2014).
Parés-Badell O; Banqué M; Macià F; Castells X; Sala M
Cancer Epidemiol; 2017 Aug; 49():66-74. PubMed ID: 28586708
[TBL] [Abstract][Full Text] [Related]
32. Using administrative health data to describe colorectal and lung cancer care in New South Wales, Australia: a validation study.
Goldsbury DE; Armstrong K; Simonella L; Armstrong BK; O'Connell DL
BMC Health Serv Res; 2012 Nov; 12():387. PubMed ID: 23140341
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy underutilisation and its impact on local control and survival in New South Wales, Australia.
Merie R; Gabriel G; Shafiq J; Vinod S; Barton M; Delaney GP
Radiother Oncol; 2019 Dec; 141():41-47. PubMed ID: 31606225
[TBL] [Abstract][Full Text] [Related]
34. A comparison of comorbidity measures for predicting mortality after elective hip and knee replacement: A cohort study of data from the National Joint Registry in England and Wales.
Penfold CM; Whitehouse MR; Blom AW; Judge A; Wilkinson JM; Sayers A
PLoS One; 2021; 16(8):e0255602. PubMed ID: 34383814
[TBL] [Abstract][Full Text] [Related]
35. Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.
Jordan JH; Thwin SS; Lash TL; Buist DS; Field TS; Haque R; Pawloski PA; Petersen HV; Prout MN; Quinn VP; Yood MU; Silliman RA; Geiger AM
Breast Cancer Res Treat; 2014 Jul; 146(2):401-9. PubMed ID: 24939060
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study.
Joseph K; Zebak S; Alba V; Mah K; Au C; Vos L; Ghosh S; Abraham A; Chafe S; Wiebe E; Liu HW; Chambers C; Gabos Z; Tankel K; Lupichuk S; King K
Radiother Oncol; 2021 Jan; 154():93-100. PubMed ID: 32941956
[TBL] [Abstract][Full Text] [Related]
37. Association of Utilization Management Policy With Uptake of Hypofractionated Radiotherapy Among Patients With Early-Stage Breast Cancer.
Parikh RB; Fishman E; Chi W; Zimmerman RP; Gupta A; Barron JJ; Sylwestrzak G; Bekelman JE
JAMA Oncol; 2020 Jun; 6(6):839-846. PubMed ID: 32297905
[TBL] [Abstract][Full Text] [Related]
38. Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03).
Wong ML; McMurry TL; Schumacher JR; Hu CY; Stukenborg GJ; Francescatti AB; Greenberg CC; Chang GJ; McKellar DP; Walter LC; Kozower BD
J Oncol Pract; 2018 Oct; 14(10):e631-e643. PubMed ID: 30207852
[TBL] [Abstract][Full Text] [Related]
39. Older age and comorbidity in breast cancer: is RT alone the new therapeutic frontier?
La Rocca E; Meneghini E; Lozza L; Fiorentino A; Vitullo A; Giandini C; Bonfantini F; Di Cosimo S; Gennaro M; Sant M; Pignoli E; Valdagni R; De Santis MC
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1791-1800. PubMed ID: 32405744
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
